lymphotoxin-alpha

Preferred Label : lymphotoxin-alpha;

MeSH definition : A tumor necrosis factor family member that is released by activated LYMPHOCYTES. Soluble lymphotoxin is specific for TUMOR NECROSIS FACTOR RECEPTOR TYPE I; TUMOR NECROSIS FACTOR RECEPTOR TYPE II; and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14. Lymphotoxin-alpha can form a membrane-bound heterodimer with LYMPHOTOXIN-BETA that has specificity for the LYMPHOTOXIN BETA RECEPTOR.;

MeSH synonym : tnf superfamily, member 1; tumor necrosis factor-beta; tumor necrosis factor beta; alpha lymphotoxin; alpha-lymphotoxin; lymphotoxin; tnf-beta; tumor necrosis factor ligand superfamily member 1; lymphotoxin alpha;

MeSH hyponym : Lymphotoxin-alpha3; Lymphotoxin alpha3; Soluble Lymphotoxin-alpha; Lymphotoxin-alpha, Soluble; Soluble Lymphotoxin alpha;

MeSH annotation : for lymphocytotoxin use CYTOTOXINS and LYMPHOCYTES;

Wikipedia link : https://en.wikipedia.org/wiki/Lymphotoxin;

Is substance : O;

Details

Origin ID

D008233;

UMLS CUI

C0024320;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Lymphotoxin-Alpha [NCIt concept]
- Tumor necrosis factor beta (substance) [SNOMED CT concept]
- lymphotoxin [SNOMED Notion]
- tumor necrosis factor beta [SNOMED Notion]
False automatic mappings
- Recombinant Tumor Necrosis Factor-Beta [NCIt concept]
Indexing information
- pateclizumab [MeSH Supplementary Concept]
Record concept(s)
- Lymphotoxin-alpha3 [MeSH concept]
- lymphotoxin-alpha [MeSH concept]
Related MeSH Supplementary Concept(s)
- C9RP protein, human [MeSH Supplementary Concept]
- LTA protein, human [MeSH Supplementary Concept]
- anti-treponemal lymphotoxin [MeSH Supplementary Concept]
- lymphocyte effector molecules [MeSH Supplementary Concept]
- mutein 2 [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- Tumor necrosis factor beta (substance) [SNOMED CT concept]
- lymphotoxin [SNOMED Notion]
- tumor necrosis factor beta [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients